This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Gastric emptying

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The passage of gastric contents from the stomach into the small intestine is influenced by many factors:

  • content of the meal - content of food material in the duodenum influences the rate of gastric emptying. The calorific value of the food seems to be the major determinant of inhibition of gastric motility, ie fats are the most inhibitory.
  • hyperglycaemia - this reduces vagal tone to the stomach and thus slows gastric emptying
  • peptides that are associated with delayed gastric emptying include gastrin, cholecystokinin, vasoactive intestinal polypeptide and gastric inhibitory peptide.
  • abdominal pain and bowel distension are associated with delayed gastric emptying.
  • atrophic gastritis is associated with a delayed gastric emptying.
  • vagotomy - this reduces gastric emptying - in this situation the gastric intrinsic nerves remain intact and still release acetylcholine in response to drugs such as metoclopramide
  • drugs e.g. anti-parkinsonism drugs cause delayed gastric emptying by blocking cholinergic muscuranic receptors and by being dopamine agonists
  • dumping syndrome - this results in accelerated gastric emptying and results from the emptying of hyperosmolar nutrients into the small intestine.

Note that a succusion splash may accompany delayed gastric emptying.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.